Maci 3CM x 5CM implant sheets
Ended Awarded Last action
- Contract number
- SPE2DR26FQPU4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,176
Award facts
- Contract value 100% obligated
- $63,175.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $63,175.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for MACI 3cm x 5cm implant sheets. The award, issued on November 18, 2025, with an ultimate completion date of December 10, 2025, carries no set-aside designation and represents DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. This delivery order is issued under the company's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025, with a $500 million ceiling value extending through December 31, 2036.
The PPV-G GEN V program, part of the broader $30.3 billion acquisition strategy, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, and specialty surgical products including MACI implants, positioning the company as a critical supplier within the federal pharmaceutical supply chain serving military healthcare facilities worldwide. No subcontractors have been identified in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FQPU4?
SPE2DR26FQPU4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FQPU4 worth?
The government has obligated $63,176 on SPE2DR26FQPU4.
Is contract SPE2DR26FQPU4 an order under another contract?
Yes. SPE2DR26FQPU4 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQPU4 competed?
The extent of competition for SPE2DR26FQPU4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award